Human osteoporosis gene
    71.
    发明申请
    Human osteoporosis gene 审中-公开
    人类骨质疏松症基因

    公开(公告)号:US20030176344A1

    公开(公告)日:2003-09-18

    申请号:US10346723

    申请日:2003-01-16

    CPC分类号: C12Q1/6883 C12Q2600/156

    摘要: A role of the human BMP2 nucleic acid in osteoporosis is disclosed. Methods for diagnosis, prediction of clinical course and treatment for osteoporosis or a susceptibility to osteoporosis using polymorphisms in the BMP2 nucleic acid, alone or in combination with other assays, are also disclosed.

    摘要翻译: 公开了人BMP2核酸在骨质疏松症中的作用。 还公开了诊断,临床病程预测和骨质疏松症治疗或使用BMP2核酸中多态性单独或与其他测定组合的骨质疏松易感性的方法。

    Nucleic acid isolation method and apparatus for performing same
    73.
    发明申请
    Nucleic acid isolation method and apparatus for performing same 审中-公开
    核酸分离方法及其执行装置

    公开(公告)号:US20030087293A1

    公开(公告)日:2003-05-08

    申请号:US10268598

    申请日:2002-10-10

    发明人: Pall Gestsson

    IPC分类号: C12Q001/68 C12M001/34

    摘要: Methods for purifying nucleic acids from biological fluids are disclosed as well as an apparatus for preforming the methods. The methods and apparatus circumvent traditional centrifugation steps using a plurality of vacuum steps to separate and isolate nucleic acids. The vacuum processing and apparatus allow the direct collection of bound nucleic acids from to collection vessels avoiding further manipulation.

    摘要翻译: 公开了从生物流体中纯化核酸的方法以及用于预处理方法的装置。 该方法和设备绕过传统的离心步骤,使用多个真空步骤来分离和分离核酸。 真空处理和装置允许从收集容器直接收集结合的核酸,避免进一步的操作。

    Drug advice expert
    74.
    发明申请
    Drug advice expert 审中-公开
    药物咨询专家

    公开(公告)号:US20020173993A1

    公开(公告)日:2002-11-21

    申请号:US10138097

    申请日:2002-05-02

    IPC分类号: G06F017/60

    摘要: A user-interactive computer program provides drug advice. Drugs are grouped according to their clinical and chemical characteristics in a supporting data base. For each drug, a drug database contains detailed information on pharmacokinetics, pharmaco-dynamics and drug-specific details. In response to user interaction with areas displayed on the screen, the computer program obtains pertinent drug interaction information from the database. With the obtained information, the computer program supports display of graphical screen views. Contents of the screen views include symbols for indicating respective drugs, geometrically distinguishing lines for indicating interaction between drugs, and text descriptions of drug information. Further included in the screen views are respective symbols for indicating drug warnings for pregnant or lactating women and sportspersons. Color coding may also be employed in the screen views to indicate degree of effect or warning.

    摘要翻译: 用户交互式计算机程序提供药物咨询。 药物根据其临床和化学特性在支持数据库中分组。 对于每种药物,药物数据库包含药代动力学,药物动力学和药物特异性细节的详细信息。 响应于与屏幕上显示的区域的用户交互,计算机程序从数据库获得相关药物交互信息。 通过获得的信息,计算机程序支持显示图形屏幕视图。 屏幕视图的内容包括用于指示各种药物的符号,用于指示药物之间的相互作用的几何区分线和药物信息的文本描述。 进一步包括在屏幕视图中的是用于表示怀孕或哺乳期妇女和运动员的药物警告的各自的符号。 也可以在屏幕视图中使用颜色编码来指示效果或警告的程度。

    GENETIC VARIANTS FOR PREDICTING RISK OF BREAST CANCER
    76.
    发明申请
    GENETIC VARIANTS FOR PREDICTING RISK OF BREAST CANCER 审中-公开
    用于预测乳腺癌风险的遗传变异

    公开(公告)号:US20140329719A1

    公开(公告)日:2014-11-06

    申请号:US14126828

    申请日:2012-06-14

    IPC分类号: C12Q1/68 G06F19/10

    摘要: The invention pertains to certain genetic variants that have been determined to be susceptibility variants of breast cancer. Methods of disease management, including diagnosing increased susceptibility to breast cancer, methods of predicting response to therapy and methods of predicting prognosis using such variants are described. The invention further relates to kit, medium and apparatus useful for assessing risk of breast cancer.

    摘要翻译: 本发明涉及已确定为乳腺癌易感性变体的某些遗传变体。 描述了疾病管理方法,包括诊断乳腺癌易感性增加,预测治疗反应的方法和使用这些变体预测预后的方法。 本发明还涉及可用于评估乳腺癌风险的试剂盒,培养基和装置。

    GENETIC VARIANTS ON CHR 5P12 AND 10Q26 AS MARKERS FOR USE IN BREAST CANCER RISK ASSESSMENT, DIAGNOSIS, PROGNOSIS AND TREATMENT
    79.
    发明申请
    GENETIC VARIANTS ON CHR 5P12 AND 10Q26 AS MARKERS FOR USE IN BREAST CANCER RISK ASSESSMENT, DIAGNOSIS, PROGNOSIS AND TREATMENT 审中-公开
    以CHR 5P12和10Q26为基础的遗传变异作为乳腺癌风险评估,诊断,预防和治疗的标志

    公开(公告)号:US20140179546A1

    公开(公告)日:2014-06-26

    申请号:US14050052

    申请日:2013-10-09

    IPC分类号: C12Q1/68

    摘要: The invention pertains to certain genetic variants on Chr5p12 and Chr10q26 as susceptibility variants of breast cancer. Methods of disease management, including diagnosing increased and/or decreased susceptibility to breast cancer, methods of predicting response to therapy and methods of predicting prognosis using such variants are described. The invention further relates to kits useful in the methods of the invention.

    摘要翻译: 本发明涉及Chr5p12和Chr10q26上的某些遗传变体作为乳腺癌的易感性变体。 描述了疾病管理方法,包括诊断乳腺癌增加和/或降低的易感性,预测治疗反应的方法和使用这些变体预测预后的方法。 本发明还涉及可用于本发明方法的试剂盒。

    GENETIC RISK FACTORS OF SICK SINUS SYNDROME
    80.
    发明申请
    GENETIC RISK FACTORS OF SICK SINUS SYNDROME 审中-公开
    SICK SINUS综合征的遗传风险因素

    公开(公告)号:US20130338012A1

    公开(公告)日:2013-12-19

    申请号:US13988268

    申请日:2011-11-17

    IPC分类号: C12Q1/68

    摘要: It has been found that certain alleles of the human MYH6 gene are predictive of risk of certain conditions, including Sick Sinus Syndrome, Atrial Fibrillation, Pacemaker implantation and Thoracic aortic aneurysm, in humans. The invention provides diagnostic applications using such alleles, including methods of determining a susceptibility of Sick Sinus Syndrome and related conditions.

    摘要翻译: 已经发现人类MYH6基因的某些等位基因预测人类患有某些病症的风险,包括病态窦综合征,心房颤动,起搏器植入和胸主动脉瘤。 本发明提供了使用这种等位基因的诊断应用,包括确定病态窦综合征易感性的方法和相关条件。